Asia Pacific Phentermine Hydrochloride Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Capsules, Orally Disintegrating Tablets (ODT), Extended-Release Formulations), By Strength (8 mg, 15 mg, 18.75 mg, 30 mg), By Country (China, South Korea, Japan, India, Australia, Singapore, Taiwan, Southeast Asia) and Forecast, 2026-2034

Table of Contents

1. Executive Summary
   1. Introduction
2. Market Introduction
   1. Market Definition
   2. Scope of the Study
   3. Market Structure
3. Research Methodology
   1. Primary Research
   2. Research Methodology
   3. Assumptions & Exclusions
   4. Secondary Data Sources
4. Market Factor Analysis
   1. Value Chain Analysis: Asia Pacific Phentermine Hydrochloride Market
   2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
5. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
6. Recent Trends Analysis
7. Impact of COVID-19 on Asia Pacific Phentermine Hydrochloride Market
   1. Pre and Post Covid -19 Market Scenario Analysis
   2. Market Recovery Timeline and Challenge
   3. Measures Taken by Top Players
8. Regulatory Landscape
9. Asia Pacific Phentermine Hydrochloride Market, By Dosage Form
   1. Introduction
      1. Market Size and Forecast, By Dosage Form
   2. Tablets
      1. Market Size and Forecast, By Region
   3. Capsules
      1. Market Size and Forecast, By Region
   4. Orally Disintegrating Tablets (ODT)
      1. Market Size and Forecast, By Region
   5. Extended-Release Formulations
      1. Market Size and Forecast, By Region
10. Asia Pacific Phentermine Hydrochloride Market, By Strength
    1. Introduction
       1. Market Size and Forecast, By Strength
    2. 8 mg
       1. Market Size and Forecast, By Region
    3. 15 mg
       1. Market Size and Forecast, By Region
    4. 18.75 mg
       1. Market Size and Forecast, By Region
    5. 30 mg
       1. Market Size and Forecast, By Region
    6. 37.5 mg
       1. Market Size and Forecast, By Region
11. Asia Pacific Phentermine Hydrochloride Market, By Route of Administration
    1. Introduction
       1. Market Size and Forecast, By Route of Administration
    2. Oral
       1. Market Size and Forecast, By Region
    3. Sublingual
       1. Market Size and Forecast, By Region
12. Asia Pacific Phentermine Hydrochloride Market, By Distribution Channel
    1. Introduction
       1. Market Size and Forecast, By Distribution Channel
    2. Hospital Pharmacies
       1. Market Size and Forecast, By Region
    3. Retail Pharmacies
       1. Market Size and Forecast, By Region
    4. Online Pharmacies
       1. Market Size and Forecast, By Region
    5. Weight Loss Clinics
       1. Market Size and Forecast, By Region
13. Asia Pacific Phentermine Hydrochloride Market, By Application
    1. Introduction
       1. Market Size and Forecast, By Application
    2. Obesity (BMI ≥30)
       1. Market Size and Forecast, By Region
    3. Overweight with Comorbidities (BMI ≥27 with conditions like hypertension, diabetes)
       1. Market Size and Forecast, By Region
14. Asia Pacific Phentermine Hydrochloride Market, By End User
    1. Introduction
       1. Market Size and Forecast, By End User
    2. Hospitals
       1. Market Size and Forecast, By Region
    3. Ambulatory Surgical Centers
       1. Market Size and Forecast, By Region
    4. Specialty Weight Loss Clinics
       1. Market Size and Forecast, By Region
    5. Homecare/Telehealth Users
       1. Market Size and Forecast, By Region
15. Asia Pacific Phentermine Hydrochloride Market, By Sales Type
    1. Introduction
       1. Market Size and Forecast, By Sales Type
    2. Branded Drugs
       1. Market Size and Forecast, By Region
    3. Generic Drugs
       1. Market Size and Forecast, By Region
16. Regional Overview
    1. Introduction
       1. Market Size and Forecast
    2. Asia Pacific
       1. Market Size and Forecast
          1. By Dosage Form
             1. Tablets
             2. Capsules
             3. Orally Disintegrating Tablets (ODT)
             4. Extended-Release Formulations
          2. By Strength
             1. 8 mg
             2. 15 mg
             3. 18.75 mg
             4. 30 mg
             5. 37.5 mg
          3. By Route of Administration
             1. Oral
             2. Sublingual
          4. By Distribution Channel
             1. Hospital Pharmacies
             2. Retail Pharmacies
             3. Online Pharmacies
             4. Weight Loss Clinics
          5. By Application
             1. Obesity (BMI ≥30)
             2. Overweight with Comorbidities (BMI ≥27 with conditions like hypertension, diabetes)
          6. By End User
             1. Hospitals
             2. Ambulatory Surgical Centers
             3. Specialty Weight Loss Clinics
             4. Homecare/Telehealth Users
          7. By Sales Type
             1. Branded Drugs
             2. Generic Drugs
       2. China
          1. By Dosage Form
             1. Tablets
             2. Capsules
             3. Orally Disintegrating Tablets (ODT)
             4. Extended-Release Formulations
          2. By Strength
             1. 8 mg
             2. 15 mg
             3. 18.75 mg
             4. 30 mg
             5. 37.5 mg
          3. By Route of Administration
             1. Oral
             2. Sublingual
          4. By Distribution Channel
             1. Hospital Pharmacies
             2. Retail Pharmacies
             3. Online Pharmacies
             4. Weight Loss Clinics
          5. By Application
             1. Obesity (BMI ≥30)
             2. Overweight with Comorbidities (BMI ≥27 with conditions like hypertension, diabetes)
          6. By End User
             1. Hospitals
             2. Ambulatory Surgical Centers
             3. Specialty Weight Loss Clinics
             4. Homecare/Telehealth Users
          7. By Sales Type
             1. Branded Drugs
             2. Generic Drugs
       3. Korea
       4. Japan
       5. India
       6. Australia
       7. Taiwan
       8. South East Asia
       9. Rest of Asia-Pacific
17. Competitive Landscape, 2025
    1. Introduction
    2. Asia Pacific Phentermine Hydrochloride Market Share Analysis, 2025 (%)
       1. Market Share Analysis, 2025
       2. Competition Ranking, 2025
       3. Key Developments & Growth Strategies
          1. Merger & Acquisition
          2. Product Launch
          3. Expansion
       4. Consolidated SWOT Analysis of Key Players
18. Company Profile
    1. KVK-Tech, Inc.
       1. Business Overview
       2. Financial Data
       3. Key Product domains
       4. Recent Developments
    2. Lannett Company, Inc.
    3. Teva Pharmaceutical Industries Ltd.
    4. Sandoz
    5. Sun Pharmaceutical Industries Ltd.
    6. Aurobindo Pharma Limited
    7. Dr. Reddy's Laboratories Ltd.
    8. Amneal Pharmaceuticals, Inc.
    9. Alvogen
    10. Hikma Pharmaceuticals PLC
    11. Lupin Limited
    12. Torrent Pharmaceuticals Ltd.